Trelion Pharmaceuticals

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.

Viamet Metaverde LLC, led by Michael Von Irvin, RN BSN MBA, is an innovative hub focused on transforming healthcare education, safety, energy, and technology through a diverse range of cutting-edge ventures. With initiatives like Aivala.com for AI training in healthcare and Billionaires.University for wealth-building strategies, the company aims to address real-world challenges and enhance various industries. The organization is committed to leveraging artificial intelligence and operational excellence across multiple sectors, including fire protection and nuclear energy logistics. By uniting these ventures under Metaverde LLC, the company strives to create a lasting legacy of innovation while fostering connections among visionaries to shape the future. Generated from the website

Merck Pharmaceutical, based in Wilson, NC, is a premier research-intensive biopharmaceutical company dedicated to improving global health through the development of innovative medicines and vaccines. With over 130 years of history, Merck focuses on various therapeutic areas including oncology, vaccines, and infectious diseases, striving to make significant advancements in patient care. The company is committed to sustainability and responsible operations, aiming to create a safe and healthy future for communities worldwide. Through initiatives like the Merck Patient Assistance Program and research collaborations, Merck actively supports both patients and medical professionals in accessing vital healthcare resources and information. Generated from the website